Lv2
170 积分 2024-08-30 加入
Fluorescent AIE-Active Materials for Two-Photon Bioimaging Applications
2个月前
已完结
Quantitation of calreticulin exposure associated with immunogenic cell death
3个月前
已完结
Fullerenols boosting the therapeutic effect of anti-CD47 antibody to trigger robust anti-tumor immunity by inducing calreticulin exposure
3个月前
已完结
Calreticulin exposure induced by anticancer drugs is associated with the p53 signaling pathway in colorectal cancer cells
3个月前
已完结
An Endoplasmic Reticulum Stress‐Specific Nanoinducer Selectively Evokes Type‐II Immunogenic Cell Death for Pyroptotic Cancer Immunotherapy
3个月前
已完结
Nanomedicines for an Enhanced Immunogenic Cell Death-Based In Situ Cancer Vaccination Response
3个月前
已完结
Calreticulin exposure dictates the immunogenicity of cancer cell death
3个月前
已完结
The Next Decade of Immune Checkpoint Therapy
4个月前
已完结
236 In vivo-generated TagCAR T cells inhibit solid tumor growth following treatment with bispecific small molecule TumorTags
5个月前
已完结
Potent induction of antitumor immunity by combining cryo‐thermal ablation with immune checkpoint inhibitors in hepatocellular carcinoma
5个月前
已完结
PCK1 deficiency promotes MASH-HCC progression by 12-HETE-induced CD8 + T cell dysfunction
3个月前
已采纳
PCK1 deficiency promotes MASH-HCC progression by 12-HETE-induced CD8 + T cell dysfunction
3个月前
已采纳
PCK1 deficiency promotes MASH-HCC progression by 12-HETE-induced CD8 + T cell dysfunction
3个月前
已采纳
PCK1 deficiency promotes MASH-HCC progression by 12-HETE-induced CD8 + T cell dysfunction
3个月前
已采纳
PCK1 deficiency promotes MASH-HCC progression by 12-HETE-induced CD8 + T cell dysfunction
3个月前
已采纳
PCK1 deficiency promotes MASH-HCC progression by 12-HETE-induced CD8+ T cell dysfunction
3个月前
已采纳
PCK1 deficiency promotes MASH-HCC progression by 12-HETE-induced CD8 + T cell dysfunction
3个月前
已采纳
皖公网安备34019202002308
